← Eichor
Study identifier: NCT06639477 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Assessing Improvements in Mood and Sleep Trial

Condition: Depression · Suicidality · Sleep  ·  Sponsor: University of Pittsburgh

PhaseNA
Planned participants420
Who can joinAll sexes, 55 Years to no upper limit
Healthy volunteersNo

About this study

This is a multi-site randomized control trial involving people age 55+ years who have current depression symptoms plus another suicide risk indicator (either current suicidal ideation or a past history of attempt). Our goal is evaluate which of two different approaches works best to improve things like trouble sleeping, bad moods, and any suicidality. Participants will complete diagnostic interviews, self-report scales, and wear an actigraphy device for the 8 weeks starting at the baseline visit.

This description comes directly from the study's public registry record.

Talk to the study team

Sara Sellars, M.A  ·  412-246-5963  ·  alberts3@upmc.edu

Stephen Smagula, Ph.D  ·  412-246-6674  ·  smagulasf@upmc.edu

Always discuss trial participation with your own doctor first.

Locations (3)

The Regents of the University of California, Los AngelesLos Angeles, California, United StatesRecruiting
Augusta UniversityAugusta, Georgia, United StatesRecruiting
University of PittsburghPittsburgh, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06639477